Mark Cuban Proposes Healthcare Reform to Texas Lawmakers

The billionaire investor presented a plan to improve drug affordability during a state hearing on September 1, 2026.

Updated on Oct. 21, 2026 in Healthcare

Bold flat-color editorial illustration featuring repeating medicine bottles, symbolizing systemic healthcare reform and drug cost transparency. — Billionaire investor Mark Cuban testified before Texas lawmakers on Tuesday, proposing structural reforms to lower drug costs and increase healthcare transparency. AI Illustration. Upload story photo >

Live Poll

Should the government implement stricter regulations on pharmaceutical middlemen to lower consumer healthcare costs?

Mark Cuban testified before Texas House lawmakers on September 1, 2026, outlining a five-step proposal to increase healthcare transparency and lower costs for consumers. His plan focuses on challenging the influence of pharmacy benefit managers to improve access to affordable medications.

Why it matters

Cuban aims to address a system he argues lacks sufficient price competition, noting that many current contracts function as a form of contractual terrorism. His proposals seek to shift power away from dominant intermediaries to ensure patients can access cheaper prescriptions.

Current data indicates 51% of U.S. adults struggle to afford quality healthcare. Meanwhile, three firms—CVS Caremark, Express Scripts, and OptumRx—currently control approximately 80% of all drug claims in the United States.

The players

Mark Cuban

He is an American entrepreneur and investor known for founding Cost Plus Drugs to increase medication price transparency.

Josh Hawley

He serves as a U.S. Senator who has actively pushed for legislation to restructure the pharmaceutical supply chain.

Elizabeth Warren

She is a U.S. Senator focused on consumer protection and antitrust reform within the healthcare industry.

The details

Cuban advocates for allowing patients to utilize lower-cost pharmacy alternatives without sacrificing credit toward their insurance deductibles. He also drafted a model contract intended to help government entities negotiate more favorable terms when dealing with large pharmacy benefit managers.

March 2026: Sens. Hawley and Warren introduced the Break Up Big Medicine Act.
May 2026: TrumpRx added over 600 generic medications to its offerings via Cost Plus Drugs.
September 1, 2026: Mark Cuban testified before Texas House lawmakers regarding his proposal.

Market Landscape

Cuban's testimony aligns with the objectives of the Break Up Big Medicine Act to combat market consolidation. By challenging the dominance of three major pharmacy benefit managers, he aims to fundamentally restructure how prescription drug pricing is handled at a state level.

If adopted, these reforms could allow patients to access lower cash prices for medications without losing insurance benefits. This change would potentially reduce out-of-pocket costs for residents currently paying higher rates through traditional insurance channels.

The takeaway

Healthcare consumers can benefit from comparing cash prices at alternative pharmacies against their insurance co-pays. Seeking out transparent pricing models is one proactive way to mitigate high prescription drug expenses.